Moderna Announces FDA Advisory Committee Votes Unanimously in Favor of the Benefit-Risk Profile of mRNA-1010, an Investigational Seasonal Influenza Vaccine
Go back to Moderna Announces FDA Advisory Committee Votes Unanimously in Favor of the Benefit-Risk Profile of mRNA-1010, an Investigational Seasonal Influenza Vaccine| Marina Biotech, Inc. (NASDAQ: MRNA) | Delayed: 154.04 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $154.04 | 52 Week High | $0.52 | |||
| Open | $154.04 | 52 Week Low | $0.08 | |||
| Day High | $154.04 | P/E | N/A | |||
| Day Low | $154.04 | EPS | $-3.80 | |||
| Volume | 139,575 | |||||
